Director Becker Todd A sold 134,250 shares of CORZ at $10.75 on 2025-03-03, reducing stake by 40.7%; stock now $9.60, down 47.3% from 52-week high.
Director Becker Todd A executed a substantial sale of 134,250 shares at $10.75, liquidating 40.7% of his holdings in Core Scientific. The stock has deteriorated significantly since the transaction, trading 47.3% below its 52-week high of $18.23 and 10.7% below his transaction price, suggesting the sale occurred before a continued decline. The company's fundamentals remain challenged: it reported a net loss of $455,259,000.00 against quarterly revenue of $95,354,000.00, underlining persistent unprofitability. The director's prior purchase at CORZ on 2024-03-15 proved exceptionally well-timed with a 90-day return of +212.2%, but this subsequent substantial reduction in exposure differs sharply from that earlier accumulation pattern.